|
Market Cap (3-Jul) $275,671,360 (480th) |
Close (30-Jun) $3.40 |
Volume (30-Jun) 0 |
Shortsold (6-Aug) 667 (0.00%) (670th) |
|
52w High $3.12 |
52w Low $2.13 |
P/E 20.92 |
EPS 0.1 |
AFP released this announcement to the ASX on 4 May 2023, 7:32. The announcement is not marked as price sensitive, and is 1 page(s) in length and 107.66kb in size.
You can view all announcements from AFP and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from AFP | |
|---|---|
| Notice of Annual Meeting of Shareholders 2023 | 30 June 2023, 7:30 |
| Dividend/Distribution - AFP | 30 May 2023, 14:13 |
| Annual Meeting and Closing Date for Director Nominations | 26 May 2023, 14:58 |
| to announce full year results on Monday May 22 2023 | 4 May 2023, 7:32 |
| US FDA sets PDUFA date for Maxigesic IV | 1 May 2023, 7:34 |
| AFT submits Maxigesic IV packaging data to the US FDA | 18 April 2023, 7:31 |
| NEW LICENSING AND APPROVALS | 27 March 2023, 7:31 |
You must be logged in to post a reply.
AFT Pharmaceuticals 